These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6782256)

  • 1. Myocardial infarction after factor IX therapy.
    Fuerth JH; Mahrer P
    JAMA; 1981 Apr; 245(14):1455-6. PubMed ID: 6782256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myocardial infarction complicating prothrombin complex concentrate therapy in an 8-year-old boy with hemophilia A and factor VIII inhibitor.
    Karayalcin G; Goldberg B; Cherrick I; Kurer C; Bierman F; Lanzkowsky P
    Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):416-9. PubMed ID: 8214364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal myocardial infarction following therapy with prothrombin complex concentrates in a young man with hemophilia A.
    Sullivan DW; Purdy LJ; Billingham M; Glader BE
    Pediatrics; 1984 Aug; 74(2):279-81. PubMed ID: 6431390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX: the updated Norwegian experience.
    Tjønnfjord GE
    Haemophilia; 2004 Sep; 10 Suppl 2():41-5. PubMed ID: 15385045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor VIII deficiency and a factor VIII inhibitor.
    Chavin SI; Siegel DM; Rocco TA; Olson JP
    Am J Med; 1988 Aug; 85(2):245-9. PubMed ID: 3135752
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies.
    Buchanan GR; Kevy SV
    Pediatrics; 1978 Nov; 62(5):767-74. PubMed ID: 724319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging of myocardial infarction during prothrombin complex concentrate therapy of hemophilia A.
    Gruen DR; Winchester PH; Brill PW; Ramirez E
    Pediatr Radiol; 1997 Mar; 27(3):271-2. PubMed ID: 9126591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothrombin complex concentrates for clinical use.
    Chandra S; Brummelhuis HG
    Vox Sang; 1981; 41(5-6):257-73. PubMed ID: 6798760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery in patients with hemophilia and inhibitors: a review of the Norwegian experience with FEIBA.
    Tjønnfjord GE
    Semin Hematol; 2006 Apr; 43(2 Suppl 4):S18-21. PubMed ID: 16690372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitors.
    Hough RE; Hampton KK; Preston FE; Channer KS; West J; Makris M
    Br J Haematol; 2000 Dec; 111(3):974-9. PubMed ID: 11122162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial infarction after FEIBA therapy in a hemophilia-B patient with a factor IX inhibitor.
    Mizon P; Goudemand J; Jude B; Marey A
    Ann Hematol; 1992 Jun; 64(6):309-11. PubMed ID: 1637888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemophiliacs with inhibitors: therapeutic options.
    Roberts HR
    N Engl J Med; 1981 Sep; 305(13):757-8. PubMed ID: 6790992
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent improvements in the clinical treatment of coagulation factor inhibitors.
    Franchini M; Lippi G
    Semin Thromb Hemost; 2009 Nov; 35(8):806-13. PubMed ID: 20169517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated prothrombin concentrate for patients with factor VIII inhibitors.
    Kurczynski EM; Penner JA
    N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Rising factor VIII inhibitor titers after Konyne factor IX complex.
    Kasper CK; Feinstein DI
    N Engl J Med; 1976 Aug; 295(9):505-6. PubMed ID: 59902
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: Factor VIII inhibitors.
    Deykin D
    N Engl J Med; 1974 Jul; 291(4):205. PubMed ID: 4834491
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of immune tolerance in hemophiliacs with inhibitors by combined treatment with i.v. IgG, cyclophosphamide and factor VIII or IX.
    Nilsson IM; Berntorp E
    Prog Clin Biol Res; 1990; 324():69-78. PubMed ID: 2106694
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acute posterior wall infarct after factor VIII concentrate administration to a patient with severe hemophilia A].
    Lickfett L; Hagendorff A; Jung W; Pizzulli L; Brackmann HH; Lüderitz B
    Dtsch Med Wochenschr; 1998 May; 123(21):658-62. PubMed ID: 9638093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of prothrombin complex concentrates in management of bleeding in hemophiliacs with inhibitors--benefits and limitations.
    Lusher JM
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):49-52. PubMed ID: 7939776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of factor VIII inhibitor bypass activity (FEIBA): 10-year compilation of thrombotic adverse events.
    Ehrlich HJ; Henzl MJ; Gomperts ED
    Haemophilia; 2002 Mar; 8(2):83-90. PubMed ID: 11952842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.